Longevity Health Holdings, Inc.
XAGE
$0.26
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 220.01% | 3,702.98% | 4,343.29% | -71.88% | -84.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 220.01% | 3,702.98% | 4,343.29% | -71.88% | -84.96% |
| Cost of Revenue | 291.45% | 13,474.60% | 12,398.04% | 149,066.67% | -- |
| Gross Profit | 163.89% | 2,303.64% | 2,860.29% | 4,937.50% | -- |
| SG&A Expenses | 61.16% | 88.65% | 42.08% | 54.32% | 49.12% |
| Depreciation & Amortization | -16.81% | -5.52% | -8.69% | -11.94% | -13.15% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.55% | 79.40% | 68.08% | 35.82% | 6.82% |
| Operating Income | -39.77% | -42.94% | -35.66% | -15.22% | 3.71% |
| Income Before Tax | 21.90% | 36.09% | 40.14% | 54.27% | 51.47% |
| Income Tax Expenses | 137.31% | 137.31% | -- | -- | -- |
| Earnings from Continuing Operations | 20.60% | 35.16% | 41.14% | 54.88% | 52.02% |
| Earnings from Discontinued Operations | -- | -- | -100.00% | -100.00% | -100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.60% | 33.40% | 8.90% | 51.72% | 49.06% |
| EBIT | -39.77% | -42.94% | -35.66% | -15.22% | 3.71% |
| EBITDA | -40.71% | -43.76% | -36.58% | -15.74% | 3.54% |
| EPS Basic | 63.30% | 65.02% | 43.00% | 63.85% | 93.04% |
| Normalized Basic EPS | 62.74% | 65.77% | 60.24% | 62.50% | 92.60% |
| EPS Diluted | 63.30% | 65.02% | 43.00% | 63.85% | 93.04% |
| Normalized Diluted EPS | 62.74% | 65.77% | 60.24% | 62.50% | 92.60% |
| Average Basic Shares Outstanding | 115.18% | 100.46% | 57.49% | 25.75% | 39.52% |
| Average Diluted Shares Outstanding | 115.18% | 100.46% | 57.49% | 25.75% | 39.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |